Device Trial Radar · NCT07115953
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
130
Planned (sponsor's estimate)
Start
Sep 22, 2025
Primary completion
Oct 30, 2027
Study completion Apr 30, 2030
Sponsor
- Lead sponsor
- Medtronic VascularPublic (MDT)
- Sponsor type
- Industry
- First posted
- Aug 11, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the SPYRAL SWYFT sub-study is to evaluate whether renal denervation with the Symplicity Spyral system performed in the main and first order branch renal arteries yields a shorter procedure time and is as effective in reducing blood pressure than the procedural approach used in the SPYRAL HTN-ON MED and SPYRAL PIVOTAL - SPYRAL HTN-OFF MED clinical studies in an uncontrolled hypertensive population.
Conditions
- Hypertension
- Vascular Diseases
- Cardiovascular Diseases
- Chronic Kidney Diseases
- Diabetes Mellitus
Interventions
Symplicity Spyral™ multi-electrode renal denervation systemDevice
After a renal angiography according to standard procedures, subjects are treated with the renal denervation procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Procedure timeTime frame: Procedure
- Office Systolic Blood Pressure ChangeTime frame: 6 months
Locations
21 sites in 9 countries. Site status is shown where the registry gives one.
The Alfred Hospital
Melbourne, Australia · Recruiting
Royal Perth Hospital
Perth, Australia · Recruiting
Algemeen Stedelijk Ziekenhuis - Campus Aalst
Aalst, Belgium · Recruiting
18 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.